GlassScriptPhysician profile
Simona L Moore
NPI 1679502181
$2,212.46
in general payments reported to CMS, 2019-2025
20 companies · $697 in 2025
The $697 reported for 2025 was more than what 81% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $633 · 2022: $213 · 2023: $387 · 2024: $282 · 2025: $697.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,366.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,366.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,078.63 | 2021-2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $226.36 | 2024-2025 | Caplyta |
| Biohaven Pharmaceuticals, INC. | $164.64 | 2021 | |
| Abbott Laboratories | $103.46 | 2023 | Freestyle Libre 3 |
| Insulet Corporation | $85.24 | 2024 | Omnipod |
| Lilly USA, LLC | $74.86 | 2021-2025 | Zepbound, Mounjaro |
| Janssen Pharmaceuticals, INC | $60.22 | 2024-2025 | Spravato |
| Axsome Therapeutics, INC. | $56.64 | 2025 | Auvelity, Symbravo |
| Allergan, INC. | $55.27 | 2021 | |
| Pfizer INC. | $54.41 | 2023 | |
| Alkermes, INC. | $53.34 | 2025 | Aristada, Lybalvi |
| Novo Nordisk INC | $42.99 | 2021-2024 | Ozempic, Rybelsus |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $30.10 | 2021 | |
| Genentech USA, INC. | $28.61 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $21.31 | 2025 | Rexulti |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Clarus Therapeutics INC. | $17.34 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $15.89 | 2025 | Airsupra |
| Lundbeck LLC | $14.90 | 2023 | Rexulti |
| Hologic Sales and Service, LLC | $14.66 | 2023 | Thinprep 2000 Processor, Aptima |
| Merck Sharp & Dohme LLC | $13.59 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Simona Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.